相关实验视频

Updated: Jan 8, 2026

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

RAB7B作为肝硬化潜在治疗标:从蛋白质表达和生物信息学分析的见解

Jinyao Dai¹, Shuaibing Ying¹, Jie Lin²

¹State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

|December 22, 2025

概括

这项研究确定RAB7B是肝硬化进展中的关键基因,将其与线粒细胞衰变联系起来. 抑制RAB7B显示出治疗肝硬化治疗的治疗潜力.

科学领域:

肝病学和分子生物学
细胞生物学细胞生物学
生物信息学是一种生物信息学.

背景情况:

肝硬化是全球重要的健康问题,需要有效的治疗.
线粒细胞,即选择性去除受损的线粒体,与肝硬化进展有关.
了解肝硬化的分子机制对于开发新疗法至关重要.

研究的目的:

通过生物信息学研究线粒细胞衰和肝硬化之间的关联.
通过分析与线粒细胞衰变相关的基因来确定肝硬化潜在的治疗点.
阐明枢纽基因RAB7B在肝硬化病原发生中的作用.

主要方法:

对基因表达数据集的综合生物信息学分析 (GSE77627,GSE139602).
鉴定和选与线粒细胞相关的差异表达基因 (mito-DEGs).
权重基因联合表达网络分析 (WGCNA),蛋白与蛋白相互作用 (PPI) 分析,以及在细胞和动物模型中的实验验证.

主要成果:

RAB7B被确定为与肝硬化中的线粒细胞衰变相关的候选枢纽基因.
在激活的肝星细胞 (HSC) 和肝硬化小鼠模型中观察到RAB7B的高表达.
RAB7B 抑制减弱了 HSC 激活和调节了线粒体,这表明它在线粒体清除调节中的作用.

结论:

RAB7B是一种与髓相关的枢纽基因,驱动肝硬化进展.
向RAB7B为肝硬化提供了一个新的治疗策略.
这项研究提供了关于肝硬化中线粒细胞衰变的动态调节的见解.

更多相关视频

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...